19456206

Source:http://linkedlifedata.com/resource/pubmed/id/19456206

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0019196, umls-concept:C0087111, umls-concept:C1136031
pubmed:issue	6
pubmed:dateCreated	2009-5-21
pubmed:abstractText	RNA interference (RNAi) represents a promising new approach to combat viral infections, and recent developments in the field of gene therapy have increased the feasibility of clinical applications.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101125414
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/MicroRNAs
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1744-7682
pubmed:author	pubmed-author:JanssenHarry L AHL, pubmed-author:PanQiuweiQ, pubmed-author:TilanusHugo WHW, pubmed-author:van der LaanLuc J WLJ
pubmed:issnType	Electronic
pubmed:volume	9
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	713-24
pubmed:meshHeading	pubmed-meshheading:19456206-Gene Therapy, pubmed-meshheading:19456206-Genetic Vectors, pubmed-meshheading:19456206-Hepatitis C, pubmed-meshheading:19456206-Humans, pubmed-meshheading:19456206-MicroRNAs, pubmed-meshheading:19456206-RNA Interference
pubmed:year	2009
pubmed:articleTitle	Prospects of RNAi and microRNA-based therapies for hepatitis C.
pubmed:affiliation	Erasmus MC-University Medical Centre, Department of Gastroenterology & Hepatology, Rotterdam 3015 CE, The Netherlands. l.vanderlaan@erasmusmc.nl
pubmed:publicationType	Journal Article, Review, Research Support, Non-U.S. Gov't